Head and neck carcinoma CD44+ CSCs containing elevated levels of various cytokines, including TGFβ, has been reported to inhibit production of IFNγ [79], a key marker of Th1 response [62]. This evidence concerns the gene TGFB1 and head and neck carcinoma.